111 related articles for article (PubMed ID: 20586849)
1. Suppression of lymphangiogenesis induced by Flt-4 antibody in gastric low-grade mucosa-associated lymphoid tissue lymphoma by Helicobacter heilmannii infection.
Nakamura M; Matsui H; Takahashi T; Ogawa S; Tamura R; Murayama SY; Takahashi S; Tsuchimoto K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S1-6. PubMed ID: 20586849
[TBL] [Abstract][Full Text] [Related]
2. Microcirculatory alteration in low-grade gastric mucosa-associated lymphoma by Helicobacter heilmannii infection: its relation to vascular endothelial growth factor and cyclooxygenase-2.
Nakamura M; Takahashi S; Matsui H; Murayama SY; Aikawa C; Sekiya Y; Nishikawa K; Matsumoto T; Yamada H; Tsuchimoto K
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S157-60. PubMed ID: 19120890
[TBL] [Abstract][Full Text] [Related]
3. Increased apoptosis and angiogenesis in gastric low-grade mucosa-associated lymphoid tissue-type lymphoma by Helicobacter heilmannii infection in C57/BL6 mice.
Nishikawa K; Nakamura M; Takahashi S; Matsui H; Murayama SY; Matsumoto T; Yamada H; Tsuchimoto K
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):268-72. PubMed ID: 17488330
[TBL] [Abstract][Full Text] [Related]
4. Alteration of angiogenesis in Helicobacter heilmannii-induced mucosa-associated lymphoid tissue lymphoma: interaction with c-Met and hepatocyte growth factor.
Nakamura M; Takahashi T; Matsui H; Baniwa Y; Takahashi S; Murayama SY; Serizawa H; Suzuki H; Hibi T
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():70-6. PubMed ID: 25521737
[TBL] [Abstract][Full Text] [Related]
5. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
6. "Candidatus Helicobacter heilmannii" from a cynomolgus monkey induces gastric mucosa-associated lymphoid tissue lymphomas in C57BL/6 mice.
Nakamura M; Murayama SY; Serizawa H; Sekiya Y; Eguchi M; Takahashi S; Nishikawa K; Takahashi T; Matsumoto T; Yamada H; Hibi T; Tsuchimoto K; Matsui H
Infect Immun; 2007 Mar; 75(3):1214-22. PubMed ID: 17194807
[TBL] [Abstract][Full Text] [Related]
7. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of 'Helicobacter heilmannii' infection.
O'Rourke JL; Dixon MF; Jack A; Enno A; Lee A
J Pathol; 2004 Aug; 203(4):896-903. PubMed ID: 15258991
[TBL] [Abstract][Full Text] [Related]
8. Interaction of VEGF to gastric low grade MALT lymphoma by Helicobacter heilmannii infection in C57/BL/6 mice.
Nakamura M; Matsui H; Murayama SY; Matsumoto T; Yamada H; Takahashi S; Tsuchimoto K
Inflammopharmacology; 2007 Jun; 15(3):115-8. PubMed ID: 19847951
[TBL] [Abstract][Full Text] [Related]
9. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
[TBL] [Abstract][Full Text] [Related]
10. Induction of high endothelial venule-like vessels expressing GlcNAc6ST-1-mediated L-selectin ligand carbohydrate and mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in a mouse model of "Candidatus Helicobacter heilmannii"-induced gastritis and gastric mucosa-associated lymphoid tissue (MALT) lymphoma.
Suzuki A; Kobayashi M; Matsuda K; Matsumoto T; Kawakubo M; Kumazawa S; Koide N; Miyagawa S; Ota H
Helicobacter; 2010 Dec; 15(6):538-48. PubMed ID: 21073611
[TBL] [Abstract][Full Text] [Related]
11. Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice.
Enno A; O'Rourke J; Braye S; Howlett R; Lee A
Am J Pathol; 1998 Jun; 152(6):1625-32. PubMed ID: 9626066
[TBL] [Abstract][Full Text] [Related]
12. New pharmaceutical treatment of gastric MALT lymphoma: anti-angiogenesis treatment using VEGF receptor antibodies and celecoxib.
Nakamura M; Takahashi T; Matsui H; Takahashi S; Murayama SY; Suzuki H; Tsuchimoto K
Curr Pharm Des; 2014; 20(7):1097-103. PubMed ID: 23782142
[TBL] [Abstract][Full Text] [Related]
13. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
[TBL] [Abstract][Full Text] [Related]
14. Mouse Models for Assessing the Protective Efficacy of Lactobacillus gasseri SBT2055 against Helicobacter suis Infection Associated with the Development of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
Matsui H; Takahashi T; Øverby A; Murayama SY; Yoshida H; Yamamoto Y; Nishiyama K; Seto Y; Takahashi T; Mukai T; Nakamura M
Helicobacter; 2015 Aug; 20(4):291-8. PubMed ID: 25627811
[TBL] [Abstract][Full Text] [Related]
15. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
[TBL] [Abstract][Full Text] [Related]
17. [Low-grade gastric MALT lymphoma and helicobacter heilmannii (Gastrospirillum hominis].
Regimbeau C; Karsenti D; Durand V; D'Alteroche L; Copie-Bergman C; Metman EH; Machet MC
Gastroenterol Clin Biol; 1998; 22(8-9):720-3. PubMed ID: 9823561
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic regeneration: new insights from VEGFR-3 blockade.
Aoki Y; Tosato G
J Natl Cancer Inst; 2005 Jan; 97(1):2-3. PubMed ID: 15632367
[No Abstract] [Full Text] [Related]
19. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue.
Dogan A; Du M; Koulis A; Briskin MJ; Isaacson PG
Am J Pathol; 1997 Nov; 151(5):1361-9. PubMed ID: 9358762
[TBL] [Abstract][Full Text] [Related]
20. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
